☆Novo Holdings A/S
Quality Q
0.595
AUM ($M)
1,722
Positions
25
Turnover
0.26
Top-10 wt
73%
Herfindahl
0.070
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 28 positions · portfolio value $1,722M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | HOLD | — | 12.6% | -1.0% | 217.4 | 5,350,000 | +0 | 5 | — |
| ☆ASML funds › | ASML HOLDING N V | HOLD | — | 11.0% | +0.8% | 188.9 | 94,946 | +0 | 5 | — |
| ☆COAG funds › | HEMAB THERAPEUTICS HLDGS INC | NEW | — | 8.9% | +8.9% | 153.6 | 4,180,550 | +4,180,550 | 1 | — |
| ☆BN funds › | BROOKFIELD CORP | HOLD | — | 8.7% | -2.8% | 149.5 | 3,496,245 | +0 | 5 | — |
| ☆MPLT funds › | MAPLIGHT THERAPEUTICS INC | HOLD | — | 7.7% | +1.6% | 132.1 | 3,686,622 | +0 | 3 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | TRIM | — | 7.6% | -2.3% | 131.7 | 1,125,000 | -200,000 | 5 | — |
| ☆AVLN funds › | AVALYN PHARMACEUTICALS INC | NEW | — | 7.4% | +7.4% | 127.8 | 3,883,289 | +3,883,289 | 1 | — |
| ☆CRM funds › | SALESFORCE INC | HOLD | — | 3.6% | -2.4% | 61.6 | 393,187 | +0 | 5 | — |
| ☆AVBP funds › | ARRIVENT BIOPHARMA INC | TRIM | — | 3.0% | -0.6% | 52.1 | 1,500,000 | -442,142 | 5 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | TRIM | — | 2.9% | -1.1% | 50.8 | 1,000,000 | -280,000 | 5 | — |
| ☆CRNX funds › | CRINETICS PHARMACEUTICALS IN | TRIM | — | 2.9% | -1.7% | 49.4 | 1,320,000 | -230,000 | 5 | — |
| ☆PHVS funds › | PHARVARIS N V | TRIM | — | 2.8% | -1.2% | 48.4 | 1,400,000 | -350,000 | 5 | — |
| ☆FND funds › | FLOOR & DECOR HLDGS INC | NEW | — | 2.7% | +2.7% | 47.3 | 797,000 | +797,000 | 1 | — |
| ☆PCVX funds › | VAXCYTE INC | TRIM | — | 2.7% | -1.3% | 46.5 | 800,000 | -60,000 | 5 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | TRIM | — | 2.5% | -0.2% | 43.2 | 3,249,178 | -401,559 | 5 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | ADD | — | 2.3% | -0.9% | 39.2 | 2,135,000 | +135,000 | 5 | — |
| ☆CLDX funds › | CELLDEX THERAPEUTICS INC NEW | TRIM | — | 2.2% | -0.9% | 38.1 | 1,025,000 | -175,000 | 5 | — |
| ☆ALMS funds › | ALUMIS INC | NEW | — | 1.8% | +1.8% | 31.0 | 1,100,000 | +1,100,000 | 1 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 1.7% | -0.6% | 29.3 | 485,438 | +0 | 2 | — |
| ☆BABA funds › | ALIBABA GROUP HLDG LTD | HOLD | — | 1.4% | -1.2% | 24.7 | 257,327 | +0 | 5 | — |
| ☆DYN funds › | DYNE THERAPEUTICS INC | NEW | — | 1.2% | +1.2% | 21.3 | 960,394 | +960,394 | 1 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | ADD | — | 1.0% | -0.6% | 17.1 | 2,250,000 | +64,077 | 4 | — |
| ☆INSM funds › | INSMED INC | NEW | — | 0.7% | +0.7% | 12.9 | 120,723 | +120,723 | 1 | — |
| ☆CUSIP:57142B104 funds › | MARQETA INC | HOLD | — | 0.4% | +0.3% | 7.2 | 441,558 | +0 | 5 | — |
| ☆LNZA funds › | LANZATECH GLOBAL INC | HOLD | — | 0.1% | -0.1% | 1.1 | 158,148 | +0 | 4 | — |
| ☆APGE funds › | APOGEE THERAPEUTICS INC | EXIT | — | 0.0% | -3.1% | 0.0 | 0 | -450,000 | 0 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -660,000 | 0 | — |
| ☆VALN funds › | VALNEVA SE | EXIT | — | 0.0% | -0.5% | 0.0 | 0 | -1,057,421 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,722 | 25 | 0.26 | 73% | 0.070 | 0.593 | — | in |
| 2026Q1 | 1,234 | 22 | 0.15 | 74% | 0.074 | 0.764 | — | in |
| 2025Q4 | 1,288 | 24 | 0.30 | 71% | 0.066 | 0.405 | — | in |
| 2025Q3 | 1,552 | 27 | 0.11 | 73% | 0.088 | 0.803 | — | in |
| 2025Q2 | 1,417 | 29 | 0.10 | 73% | 0.089 | 0.834 | — | entered |
| 2025Q1 | 1,315 | 31 | 0.00 | 74% | 0.087 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status